ENFORTUMAB VEDOTIN

7851 reported adverse events

These side effects are most commonly reported by patients taking ENFORTUMAB VEDOTIN:

# Side effect Count
0 RASH 1019
1 NEUROPATHY PERIPHERAL 909
2 MALIGNANT NEOPLASM PROGRESSION 893
3 DIARRHOEA 503
4 PRURITUS 467
5 DEATH 436
6 DECREASED APPETITE 424
7 FATIGUE 423
8 OFF LABEL USE 362
9 ALOPECIA 324
See all common reactions for ENFORTUMAB VEDOTIN

ENFORTUMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRANSITIONAL CELL CARCINOMA METASTATIC 41 0.3504
1 TRANSITIONAL CELL CARCINOMA RECURRENT 14 0.2414
2 MICROCOCCAL SEPSIS 4 0.2000
3 PLEURISY BACTERIAL 6 0.1463
4 URINARY BLADDER HAEMATOMA 3 0.1111
5 URINARY BLADDER ATROPHY 4 0.0870
6 IMMUNE-MEDIATED ADVERSE REACTION 126 0.0820
7 TOXIC ERYTHEMA OF CHEMOTHERAPY 20 0.0772
8 KL-6 INCREASED 17 0.0752
9 INFUSION SITE EXFOLIATION 3 0.0577
See all enriched reactions for ENFORTUMAB VEDOTIN